Compare Abeona Therapeutics Inc (ABEO) vs Jones Lang LaSalle Inc (JLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Jones Lang LaSalle Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Jones Lang LaSalle Inc trades at $361.02 (market cap $16.72B). The key difference: Jones Lang LaSalle Inc is far larger — about 39.7× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Jones Lang LaSalle Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | JLL | |
|---|---|---|
Market Cap | $421.19M | $16.72B |
Sector | Health | Real Estate |
52-Week High | $7.45 | $373.24 |
52-Week Low | $4.17 | $280.16 |
Enterprise Value | $276.10M | $19.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →
